ESG Impact Zone

Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care

3BL Media

MAY 19, 2022

DESCRIPTION: SAN DIEGO, May 18, 2022 /3BL Media/ -- Illumina, Inc. If so, less-invasive CGP testing of blood samples could potentially complement tissue sampling, substantially increasing the number of patients who are able to have their tumors profiled and be part of clinical trials for cancer therapy selection. "We

Principal® Named a Best Place to Work in Money Management by Pensions & Investments for Twelfth Consecutive Year

3BL Media

DECEMBER 12, 2023

billion in total assets under management 1 , Principal Asset Management is the 27 th largest manager of institutional assets 3 in the world of those profiled by Pensions & Investments. 1 Principal Asset Management is the global investment solutions business for Principal Financial Group ® (Nasdaq: PFG), managing $506.9

New $1.1 Million Investment from Fifth Third Foundation Advances NMSDC Centers of Excellence Certificate Program

3BL Media

FEBRUARY 29, 2024

Fifth Third Bancorp is the indirect parent company of Fifth Third Bank and its common stock is traded on the NASDAQ ® Global Select Market under the symbol "FITB." Rudy Hernandez, Transworld Plastic Films Inc. Shin Kishioko, ITA Inc. Zenja Glass, Unlocking Greatness Staffing Inc. Garvita Sethi, Accede Solutions Inc.

Banking

Banking Logistics Supply Chains Supply Chain

Webinars

Manufacturing Sustainability Surge: Your Guide to Data-Driven Energy Optimization & Decarbonization

MORE WEBINARS

Principal® Named a Best Place To Work in Money Management by Pensions & Investments

3BL Media

DECEMBER 15, 2022

billion in total assets under management 2 , Principal Asset Management is the 23rd largest manager of institutional assets 3 in the world of those profiled by Pensions & Investments. 23rd out of 444 managers profiled. ©2022 Principal Financial Services, Inc. With approximately $484.6 1 1,000-plus employees.

Illumina and Pillar Biosciences Partner To Improve Access to Personalized Cancer Treatment Options

3BL Media

JULY 31, 2023

SAN DIEGO, July 31, 2023 /3BL/ -- Illumina Inc. NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Pillar Biosciences Inc., Contacts Investors: Salli Schwartz 858-291-6421 IR@illumina.com Media: David McAlpine 347-327-1336 PR@illumina.com SOURCE Illumina, Inc.

Development

Development Manufacturing

Qurate Retail, Inc. Included in 2022 Bloomberg Gender-Equality Index

3BL Media

JANUARY 26, 2022

DESCRIPTION: NEW YORK, January 26, 2022 /3BL Media/ – Qurate Retail, Inc. While all public companies are encouraged to disclose supplemental gender data for their company’s investment profile on the Bloomberg Terminal®, those that have a market capitalization of USD 1 billion are eligible for inclusion in the Index. Qurate Retail, Inc.

Analytics

Analytics Digitalization

ESG Insights for IROs

3BL Media

SEPTEMBER 20, 2022

SOURCE: Nasdaq, Inc. At Nasdaq, our IR team, in tandem with our Corporate ESG team, focuses on communicating our sustainability efforts. At Nasdaq, our IR team, in tandem with our Corporate ESG team, focuses on communicating our sustainability efforts. Insights from Nasdaq's Investor Relations Officer Ed Ditmire.

The Impact of ESG on Proxy Season and Proxy Voting

3BL Media

OCTOBER 24, 2022

SOURCE: Nasdaq, Inc. Over the last decade, Nasdaq has developed a comprehensive suite of ESG solutions to help client companies achieve their objectives. For example, Nasdaq OneReport simplifies the process of ESG data capture, engagement, oversight and disclosure. KEYWORDS: NASDAQ:NDAQ, NASDAQ, ESG.

Analytics

Analytics Development

Illumina Collaborates With National Cancer Center Japan to Address a Leading Cause of Death in Asia

3BL Media

FEBRUARY 4, 2022

DESCRIPTION: SAN DIEGO, February 4, 2022 /3BL Media/ -- Illumina, Inc. A comprehensive genome profiling panel is a powerful tool to help solve this problem by using blood for genetic analysis. This comprehensive tumor profiling assay will have similar chemistry and analytics to TSO 500. SOURCE: Illumina. About Illumina.

Development

Development Analytics

ESG Trendsetters: Xylem

3BL Media

NOVEMBER 4, 2022

SOURCE: Nasdaq, Inc. DESCRIPTION: Nasdaq's ESG Trendsetters series highlights the top ESG professionals and teams around the world who go the extra mile in their evolving ESG roles. What results did you get from your work with Nasdaq? Nasdaq has helped keep us informed and educated on these changes. Nasdaq [link].

Value Creation

Value Creation Global Economy Digitalization Development

Australia's PrOSPeCT Project Is Sequencing Thousands of Cancer Patients

3BL Media

JUNE 24, 2022

Public/private partnership expands access to comprehensive genomic profiling to improve patient care and advance drug discovery. We picked up many patients who had nowhere else to go for genomic profiling or clinical trials.”. All trademarks are the property of Illumina, Inc. SOURCE: Illumina. Uniting Australia.

Analytics

Analytics Development

Illumina and GenoScreen Partner To Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis

3BL Media

OCTOBER 19, 2022

DESCRIPTION: SAN DIEGO, October 19, 2022 /3BL Media/ -- Illumina Inc. NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative genomics company, announced a partnership to accelerate progress to end tuberculosis (TB) worldwide. KEYWORDS: NASDAQ: ILMN, illumina.

Development

Development Manufacturing

Illumina Introduces New Research Test to Address One of the Most Common Infections in the United States

3BL Media

NOVEMBER 3, 2022

DESCRIPTION: SAN DIEGO, November 3, 2022 /3BL Media/ -- Illumina, Inc. NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced a new research test for genitourinary pathogen and antimicrobial resistance (AMR) identification. Learn more here: [link].

United Airlines and PGA TOUR Team Up to Provide Travel Grants to 50+ HBCU Golf Programs

3BL Media

FEBRUARY 8, 2022

SOURCE: United Airlines Inc. Each school will receive $10,000 in travel credits, enabling more than 250 student-athletes, coaches and their equipment to fly United to compete in high-profile tournaments that were previously out of reach. United Airlines Holdings, Inc. is traded on the Nasdaq under the symbol "UAL”.

Digitalization

Digitalization Development

Northern Trust Asset Management Partners With Solactive To Launch Two Global Bond ESG Climate Index Funds

3BL Media

DECEMBER 19, 2022

In order to improve the ESG profile and reduce the carbon intensity of a fixed income portfolio, both of the funds apply distinct ESG approaches; one to corporate bonds and another to government bonds. Northern Trust Asset Management is composed of Northern Trust Investments, Inc., NT Global Advisors, Inc., DE 255 598 976.

Sustainable Investment

Sustainable Investment Banking Development

Another Way to #BeYou: T-Mobile Brings True Name® by Mastercard® to T-Mobile MONEY

3BL Media

FEBRUARY 1, 2022

Today T-Mobile (NASDAQ: TMUS) announced True Name® by Mastercard® for T-Mobile MONEY, enabling all customers, including transgender and non-binary customers, to be their authentic self with their chosen name on their T-Mobile MONEY debit card. About T-Mobile T-Mobile US, Inc. About BM Technologies, Inc. BM Technologies, Inc.

Banking

Banking Digitalization Development

Verizon Innovative Learning Celebrates 10 Years and $1B in Contributions to Education

3BL Media

JUNE 9, 2022

Presented by Verizon, TIME unveils list of Innovative Teachers, profiling 10 educators who are changing the landscape of education in America. Chosen by a team of editors at TIME, the list profiles 10 teachers who are changing the landscape of education in America through innovation. Verizon Communications Inc.

Digitalization

Digitalization Corporate Social Responsibility Development Climate Change

Gilead Sciences: WHO Expands Recommendation for Veklury® (Remdesivir) to Patients With Severe Disease in Latest Update to COVID-19 Guideline

3BL Media

SEPTEMBER 29, 2022

September 28, 2022 /3BL Media/ - Gilead Sciences, Inc. Remdesivir has an established safety profile and minimal drug interactions in diverse populations. Gilead Sciences, Inc. Veklury, Gilead and the Gilead logo are registered trademarks of Gilead Sciences, Inc., Source: Gilead Sciences, Inc. About Veklury.

Illumina Announces Long-Term Strategic Partnership with Janssen

3BL Media

MAY 2, 2022

I’m proud to announce that today, during the World CDx Summit in London, Illumina, Inc. announced a long-term strategic collaboration with Janssen Biotech, Inc. KEYWORDS: NASDAQ: ILMN, illumina, World CDx Summit, janssen biotech, Inc., Janssen) to accelerate the development of precision medicines.

Data Analytics

Data Analytics Development Analytics Manufacturing

Delivering the Future of Diagnostics and Precision Oncology

3BL Media

SEPTEMBER 9, 2022

Sementchenko and his colleagues’ abstract, “Validation of TruSight™ Oncology Comprehensive (EU) assay,” is a study to support Illumina’s first in vitro diagnostic (IVD) assay for comprehensive genomic profiling (CGP). TSO Comp is the only IVD product on the market with tumor profiling claims that analyzes both DNA and RNA.

Analytics

Analytics Development

Illumina Partners With Centers Across France to Advance a Precision Medicine Approach for Patients With Late-Stage Cancer

3BL Media

FEBRUARY 7, 2022

Joint study will assess clinical value of comprehensive genomic profiling (CGP) on cancer therapy options in patients with advanced disease. DESCRIPTION: SAN DIEGO, February 7, 2022 /3BL Media/ -- Illumina, Inc. TSO 500 is a Research Use Only pan-cancer assay that enables Comprehensive Genomic Profiling from tissue biopsy samples.

Analytics

Analytics Development

Latest Research at ESMO Congress 2022 Showcases the Impact of Comprehensive Genomic Profiling for Cancer Patients

3BL Media

SEPTEMBER 7, 2022

DESCRIPTION: SAN DIEGO, September 7, 2022 / 3BL Media / — Illumina, Inc. NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced the upcoming presentation of multiple oncology research abstracts at this year’s European Society of Medical Oncology (ESMO) annual meeting, September 9–13 in Paris. “For

Analytics

Analytics Academics

Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients With Rare Genetic Mutations to Targeted Therapy

3BL Media

MAY 24, 2022

DESCRIPTION: SAN DIEGO, May 24, 2022 /3BL Media/ -- Illumina, Inc. NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight™ Oncology (TSO) Comprehensive (EU) test. SOURCE Illumina, Inc.

Development

Development Manufacturing Analytics

Illumina Launches Research Test Codeveloped With Merck To Unlock Deeper Insights Into the Tumor Genome

3BL Media

JUNE 22, 2022

DESCRIPTION: SAN DIEGO, June 22, 2022 /3BL Media/ -- Illumina, Inc. NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of a research test, codeveloped with Merck (known as MSD outside the United States and Canada). About TruSight Oncology 500.

Development

Development Shipping

Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe

3BL Media

MARCH 16, 2022

DESCRIPTION: SAN DIEGO, March 16, 2022 /3BL Media/ -- Illumina, Inc. NASDAQ:ILMN) announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient's cancer. SOURCE: Illumina.

Manufacturing

Manufacturing Development

Illumina Unveils Its Most Accurate and Comprehensive Secondary Analysis Platform, Boosting Lab Capabilities

3BL Media

JULY 27, 2022

DESCRIPTION: SAN DIEGO, July 27, 2022 /3BL Media/ -- Illumina, Inc. NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the release of Illumina DRAGEN™ v4.0, Simultaneous profiling of transcriptome and epigenome – DRAGEN v4.0 SOURCE Illumina, Inc. DRAGEN™ v4.0 SOURCE: Illumina.

Development

Development Manufacturing

Alkermes to Highlight Data Related to Psychiatry Portfolio at Upcoming Scientific Conferences During Mental Health Awareness Month

3BL Media

MAY 6, 2022

DESCRIPTION: DUBLIN, May 6, 2022 /3BL Media/ - Alkermes plc (Nasdaq: ALKS) announced plans to present research related to its psychiatry portfolio at four scientific conferences during Mental Health Awareness Month in May. Do not substitute ARISTADA INITIO for ARISTADA because of differing pharmacokinetic profiles. SOURCE: Alkermes.

Development

Development Manufacturing

6 Cybersecurity Predictions for 2022 - From Norton Labs

3BL Media

FEBRUARY 4, 2022

Now that some of these companies, like Coinbase and Robinhood, are regulated and listed on the NASDAQ, trust and transparency in those companies is rising and the barrier to entry to use cryptocurrencies is getting lower. . Copyright © 2021 NortonLifeLock Inc. Many companies enable the buying and selling of cryptocurrencies.

Digitalization

Digitalization Development Banking Waste

ESG Impact Zone

Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care

Principal® Named a Best Place to Work in Money Management by Pensions & Investments for Twelfth Consecutive Year

Webinars

Trending Sources

New $1.1 Million Investment from Fifth Third Foundation Advances NMSDC Centers of Excellence Certificate Program

Webinars

Principal® Named a Best Place To Work in Money Management by Pensions & Investments

Illumina and Pillar Biosciences Partner To Improve Access to Personalized Cancer Treatment Options

Qurate Retail, Inc. Included in 2022 Bloomberg Gender-Equality Index

ESG Insights for IROs

The Impact of ESG on Proxy Season and Proxy Voting

Illumina Collaborates With National Cancer Center Japan to Address a Leading Cause of Death in Asia

ESG Trendsetters: Xylem

Australia's PrOSPeCT Project Is Sequencing Thousands of Cancer Patients

Illumina and GenoScreen Partner To Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis

Illumina Introduces New Research Test to Address One of the Most Common Infections in the United States

United Airlines and PGA TOUR Team Up to Provide Travel Grants to 50+ HBCU Golf Programs

Northern Trust Asset Management Partners With Solactive To Launch Two Global Bond ESG Climate Index Funds

Another Way to #BeYou: T-Mobile Brings True Name® by Mastercard® to T-Mobile MONEY

Verizon Innovative Learning Celebrates 10 Years and $1B in Contributions to Education

Gilead Sciences: WHO Expands Recommendation for Veklury® (Remdesivir) to Patients With Severe Disease in Latest Update to COVID-19 Guideline

Illumina Announces Long-Term Strategic Partnership with Janssen

Delivering the Future of Diagnostics and Precision Oncology

Illumina Partners With Centers Across France to Advance a Precision Medicine Approach for Patients With Late-Stage Cancer

Latest Research at ESMO Congress 2022 Showcases the Impact of Comprehensive Genomic Profiling for Cancer Patients

Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients With Rare Genetic Mutations to Targeted Therapy

Illumina Launches Research Test Codeveloped With Merck To Unlock Deeper Insights Into the Tumor Genome

Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe

Illumina Unveils Its Most Accurate and Comprehensive Secondary Analysis Platform, Boosting Lab Capabilities

Alkermes to Highlight Data Related to Psychiatry Portfolio at Upcoming Scientific Conferences During Mental Health Awareness Month

6 Cybersecurity Predictions for 2022 - From Norton Labs

Stay Connected